Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $795,412 - $1.23 Million
-26,558 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$38.72 - $42.52 $15,139 - $16,625
391 Added 1.49%
26,558 $1.11 Million
Q1 2018

May 09, 2018

SELL
$39.4 - $47.39 $282,813 - $340,165
-7,178 Reduced 21.53%
26,167 $1.07 Million
Q4 2017

Feb 12, 2018

BUY
$37.27 - $43.02 $24,560 - $28,350
659 Added 2.02%
33,345 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $1.1 Million - $1.36 Million
32,686
32,686 $1.31 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.